Yi Xu

机构：Jingdezhen Ceramic Institute, Southern University of Science and Technology, Wuhan University, Jingdezhen University, Zhongda Hospital Southeast University, Taiyuan Institute of Technology, Nanyang Institute of Technology, Nanyang Medical College, Renmin Hospital of Wuhan University, The First People's Hospital of Guiyang, Beijing University of Chemical Technology · ORCID：0000-0002-7401-534X

发表论文 35 篇 · 总被引 564 次 · h-index 11

代表论文

• Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR‐29a‐3p (2019 · Journal of Cellular and Molecular Medicine · 被引 140)
• Consensus for HER2 alterations testing in non-small-cell lung cancer (2022 · ESMO Open · 被引 116)
• FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III (2021 · Journal for ImmunoTherapy of Cancer · 被引 29)
• RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAs (2020 · Annals of Translational Medicine · 被引 29)
• Co nanoparticles encapsulated in N-doped carbon nanotube materials derived from new metal–organic frameworks for oxygen electrocatalysis (2024 · Journal of Materials Chemistry A · 被引 21)
• Exploring metal-organic frameworks in gene delivery: From prostate to lung therapeutics (2024 · Applied Materials Today · 被引 12)